发明授权
US07728002B2 Use of pyrrolopyridine compounds for activating PPAR receptors and treatment of conditions involving such receptors
有权
吡咯并吡啶化合物用于激活PPAR受体和治疗涉及此类受体的病症
- 专利标题： Use of pyrrolopyridine compounds for activating PPAR receptors and treatment of conditions involving such receptors
- 专利标题（中）： 吡咯并吡啶化合物用于激活PPAR受体和治疗涉及此类受体的病症
-
申请号： US12476697申请日： 2009-06-02
-
公开(公告)号： US07728002B2公开(公告)日： 2010-06-01
- 发明人: Benaïssa Boubia , Martine Barth , Jean Binet , Pierre Dodey , Christiane Legendre , Olivia Poupardin-Olivier
- 申请人： Benaïssa Boubia , Martine Barth , Jean Binet , Pierre Dodey , Christiane Legendre , Olivia Poupardin-Olivier
- 申请人地址： FR Dijon Cedex
- 专利权人： Laboratoires Fournier S.A.
- 当前专利权人： Laboratoires Fournier S.A.
- 当前专利权人地址： FR Dijon Cedex
- 代理机构： Crowell & Moring, LLP
- 优先权： FR0510482 20051014
- 主分类号： A61K31/4745
- IPC分类号： A61K31/4745 ; C07D471/04
摘要：
A method of activating PPAR receptors in a subject, said method comprising administering to said subject an effective PPAR receptor activating amount of a pyrrolopyridine compound corresponding to formula (I): wherein R, R1, R2, R3, R4, X, Ar and n have defined meanings, or a pharmaceutically acceptable salt thereof, particularly as part of the treatment of a disorder or disease state selected from the group consisting of atherosclerosis, myocardial infarction, hypertension, and cerebral vascular disease.
公开/授权文献
信息查询
IPC分类:
